STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #1919 by analyst upside · 2026-08-14
ANGO
AngioDynamics, Inc.
Healthcare · Market Cap $647M · P/E 0x
ANALYST PRICE TARGET
+27.7%
implied upside to consensus target
Current Price $15.66
Consensus Target $20.0
Bull Target $24.0
Bear Target $17.0
Analysts Covering 4
ANALYST CONSENSUS - BUY
Strong Buy
0
Buy
4
Hold
0
Sell
0
52-Week Low $8.65
52-Week High $16.11
YTD Return +23.5%
FUNDAMENTALS
Market Cap $647M
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-0.88
PEG Ratio 1.41
Dividend Yield N/A
Revenue (TTM) $320M
Profit Margin -11.5%
52-WEEK RANGE
52-Week Low $8.65
52-Week High $16.11
Current Price $15.66
Bear Target $17.0
Bull Target $24.0
● Now $15.66 ● Target $20.0
TRADING DATA
Avg Volume 452K
YTD Return +23.5%
Analyst Count 4
Consensus Buy
Upside to Target +27.7%
Last Updated 2026-08-14

ANALYST SUMMARY

AngioDynamics, Inc. (ANGO) is currently trading at $15.66 with a Wall Street consensus price target of $20.0, implying potential upside of 27.7% over the next 12 months. 4 analysts currently cover ANGO, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $24.0, while the most cautious has a target of $17.0.

ANGO operates in the Healthcare sector with a market capitalisation of $647M. The stock is up 23.5% year-to-date and is currently trading near the upper end of its 52-week range of $8.65 – $16.11.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for ANGO, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Canaccord Genuity - Reiterated
Buy → Buy 2026-04-06 Building track record
Freedom Broker ● Initiated
Buy 2026-04-06 Building track record
Canaccord Genuity - Reiterated
Buy → Buy 2025-10-03 Building track record
Lake Street ● Initiated
Buy 2025-07-16 27% win rate (11 calls)
HC Wainwright & Co. reit
Buy → Buy 2025-07-16 31% win rate (48 calls)
Canaccord Genuity - Reiterated
Buy → Buy 2025-07-16 Building track record
HC Wainwright & Co. - Reiterated
Buy → Buy 2025-04-07 31% win rate (48 calls)
HC Wainwright & Co. - Reiterated
Buy → Buy 2025-01-10 31% win rate (48 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
60
out of 100
Coverage depth
12/30
Consensus clarity
21/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →